Biotechnology Diversity: Driving Innovation #DiversityinBiotechnology

Diversity in biotechnology and venture capital is crucial for driving innovation and breakthroughs in healthcare, according to Dr. Stanley Lewis. Efforts to increase minority participation in STEM fields and remove biases in funding are important. A28 Therapeutics aims to bring AT-101, a targeted cancer treatment, to market. Diverse voices and approaches are needed for innovation in healthcare.